Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Montgomery

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Geriatric Nursing (New York, N.Y.)|February 13, 2008
Resident condition change: should I call 911?Justin Montgomery, Ethel Mitty, Sandi Flores
Journal of the American Geriatrics Society|September 8, 2016
Association Between Hospital Admission Risk Profile Score and Skilled Nursing or Acute Rehabilitation Facility Discharges in Hospitalized Older AdultsStephen K Liu, Justin Montgomery, Yu Yan, et al.
Innovation in Aging|November 28, 2018
Association of Hospital Admission Risk Profile Score with Mortality in Hospitalized Older AdultsStephen K Liu, Marshall Ward, Justin Montgomery, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 28, 2016
Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance MechanismsLouis Leung, Xin Yang, Timothy J Strelevitz, et al.
Nature Communications|December 4, 2018
Determining molecular properties with differential mobility spectrometry and machine learningStephen W C Walker, Ahdia Anwar, Jarrod M Psutka, et al.
Journal of Medicinal Chemistry|February 1, 2017
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in HumansAtli Thorarensen, Martin E Dowty, Mary Ellen Banker, et al.
Journal of Medicinal Chemistry|November 7, 2014
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitorsMark E Flanagan, Joseph A Abramite, Dennis P Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Delineating the role of cooperativity in the design of potent PROTACs for BTKAdelajda Zorba, Chuong Nguyen, Yingrong Xu, et al.
ACS Chemical Biology|October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective InhibitionJean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Geriatric Nursing (New York, N.Y.)|February 13, 2008
Resident condition change: should I call 911?Justin Montgomery, Ethel Mitty, Sandi Flores
Journal of the American Geriatrics Society|September 8, 2016
Association Between Hospital Admission Risk Profile Score and Skilled Nursing or Acute Rehabilitation Facility Discharges in Hospitalized Older AdultsStephen K Liu, Justin Montgomery, Yu Yan, et al.
Innovation in Aging|November 28, 2018
Association of Hospital Admission Risk Profile Score with Mortality in Hospitalized Older AdultsStephen K Liu, Marshall Ward, Justin Montgomery, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 28, 2016
Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance MechanismsLouis Leung, Xin Yang, Timothy J Strelevitz, et al.
Nature Communications|December 4, 2018
Determining molecular properties with differential mobility spectrometry and machine learningStephen W C Walker, Ahdia Anwar, Jarrod M Psutka, et al.
Journal of Medicinal Chemistry|February 1, 2017
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in HumansAtli Thorarensen, Martin E Dowty, Mary Ellen Banker, et al.
Journal of Medicinal Chemistry|November 7, 2014
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitorsMark E Flanagan, Joseph A Abramite, Dennis P Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Delineating the role of cooperativity in the design of potent PROTACs for BTKAdelajda Zorba, Chuong Nguyen, Yingrong Xu, et al.
ACS Chemical Biology|October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective InhibitionJean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Pageof 1